BALAXI PHARMACEUTICALS LIMITED

Healthcare

NSE: BALAXI
₹22.77
Oct. 5, 2026 · NSE · nse_bhavcopy

Quarterly Financials

Period endRevenue (₹ Cr)PBT (₹ Cr)Net profit (₹ Cr)Basic EPS
June 30, 2026 81 2 1 ₹
March 31, 2026 71 — — ₹
Dec. 31, 2025 73 2 0 ₹
Sept. 30, 2025 56 1 0 ₹
June 30, 2025 71 1 0 ₹
March 31, 2025 76 10 9 ₹
Dec. 31, 2024 73 6 5 ₹
Sept. 30, 2024 77 6 5 ₹
June 30, 2024 66 7 6 ₹
March 31, 2024 60 11 11 ₹
Dec. 31, 2023 61 14 14 ₹
Sept. 30, 2023 55 16 14 ₹
June 30, 2023 66 -39 -41 ₹

The detailed income statement is standalone-only: the consolidated feed carries just revenue, PBT and net profit.

Annual Financials

Year endedRevenue (₹ Cr)PBT (₹ Cr)Net profit (₹ Cr)
March 31, 2026 270 5 1
March 31, 2025 293 29 25
March 31, 2024 241 2 -2
March 31, 2023 336 57 46

Revenue Mix

Data unavailable.

Cash Flow

Year endedOperating (₹ Cr)Investing (₹ Cr)Financing (₹ Cr)Capex (₹ Cr)Free Cash Flow (₹ Cr)
March 31, 2026 — — — 15 —
March 31, 2025 -35 -22 34 1 -36
March 31, 2024 5 -1 30 1 4
March 31, 2023 6 -11 26 11 -5
March 31, 2022 34 -28 -0 5 29

Balance Sheet (consolidated)

Year endedTotal Assets (₹ Cr)Total Equity (₹ Cr)Reserves (₹ Cr)Borrowings, Current (₹ Cr)Borrowings, Non-current (₹ Cr)Current Assets (₹ Cr)Current Liabilities (₹ Cr)Cash & Equivalents (₹ Cr)Net Block (₹ Cr)Inventory (₹ Cr)
March 31, 2026 — — — — — — — — — —
March 31, 2025 — — — — — — — — — —
March 31, 2024 — — — — — — — — — —
March 31, 2023 — — — — — — — — — —
March 31, 2022 — — — — — — — — — —